Cargando…
Extending the Serum Half-Life of G-CSF via Fusion with the Domain III of Human Serum Albumin
Protein fusion technology is one of the most commonly used methods to extend the half-life of therapeutic proteins. In this study, in order to prolong the half-life of Granulocyte colony stimulating factor (G-CSF), the domain III of human serum albumin (3DHSA) was genetically fused to the N-terminal...
Autores principales: | Zhao, Shuqiang, Zhang, Yu, Tian, Hong, Chen, Xiaofei, Cai, Di, Yao, Wenbing, Gao, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787585/ https://www.ncbi.nlm.nih.gov/pubmed/24151579 http://dx.doi.org/10.1155/2013/107238 |
Ejemplares similares
-
Improved Biodistribution and Extended Serum Half-Life of a Bacteriophage Endolysin by Albumin Binding Domain Fusion
por: Seijsing, Johan, et al.
Publicado: (2018) -
Extension of human GCSF serum half-life by the fusion of albumin binding domain
por: Nikravesh, Fatemeh Yadavar, et al.
Publicado: (2022) -
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life
por: Adams, Ralph, et al.
Publicado: (2016) -
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding
por: Davé, Emma, et al.
Publicado: (2016) -
Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity
por: Lombardi, Silvia, et al.
Publicado: (2021)